We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$356B
AUM Growth
+$14.1B
Cap. Flow
-$4.79B
Cap. Flow %
-1.35%
Top 10 Hldgs %
30.2%
Holding
3,385
New
54
Increased
1,101
Reduced
1,417
Closed
52

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$542M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$499M
3
MNST icon
Monster Beverage
MNST
+$326M
4
NVDA icon
NVIDIA
NVDA
+$316M
5
MCD icon
McDonald's
MCD
+$302M

Sector Composition

Rank Sector Weight
1 Technology 30.77%
2 Financials 12.09%
3 Healthcare 11.08%
4 Consumer Discretionary 10.82%
5 Industrials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUE
3251
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$127K ﹤0.01%
11,873
SBT
3252
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$127K ﹤0.01%
27,857
+3,571
+15% +$19.4K
CSTE icon
3253
Caesarstone
CSTE
$76.8M
$127K ﹤0.01%
27,788
MOND
3254
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$125K ﹤0.01%
90,097
LLAP
3255
DELISTED
Terran Orbital Corporation
LLAP
$123K ﹤0.01%
491,044
ULBI icon
3256
Ultralife
ULBI
$102M
$123K ﹤0.01%
13,610
EVEX icon
3257
Eve Holding
EVEX
$965M
$117K ﹤0.01%
36,010
GUTS icon
3258
Fractyl Health
GUTS
$111M
$114K ﹤0.01%
+45,180
New +$147K
GOEV
3259
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$114K ﹤0.01%
5,795
-21,691
-79% -$728K
KYTX icon
3260
Kyverna Therapeutics
KYTX
$481M
$112K ﹤0.01%
22,848
AKYA
3261
DELISTED
Akoya BioSciences
AKYA
$111K ﹤0.01%
40,827
IVVD icon
3262
Invivyd
IVVD
$208M
$109K ﹤0.01%
107,119
LCUT icon
3263
Lifetime Brands
LCUT
$209M
$109K ﹤0.01%
16,644
OTLK icon
3264
Outlook Therapeutics
OTLK
$181M
$107K ﹤0.01%
20,079
-25,802
-56% -$189K
FBLG icon
3265
FibroBiologics
FBLG
$6.72M
$107K ﹤0.01%
1,727
ELEV
3266
DELISTED
Elevation Oncology
ELEV
$104K ﹤0.01%
174,137
+92,950
+114% +$138K
NOTE
3267
DELISTED
FiscalNote
NOTE
$104K ﹤0.01%
6,747
VSTM icon
3268
Verastem
VSTM
$537M
$103K ﹤0.01%
34,399
DLHC icon
3269
DLH Holdings
DLHC
$69.7M
$102K ﹤0.01%
10,947
EEX
3270
DELISTED
Emerald Holding
EEX
$99.4K ﹤0.01%
19,910
CHRS icon
3271
Coherus Oncology
CHRS
$213M
$98.9K ﹤0.01%
95,056
MAPS
3272
DELISTED
WM TECHNOLOGY INC A
MAPS
$97.3K ﹤0.01%
111,832
SKYE icon
3273
Skye Bioscience
SKYE
$18.3M
$91.5K ﹤0.01%
23,389
AILE
3274
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$89.2K ﹤0.01%
53,400
INMB icon
3275
INmune Bio
INMB
$54.2M
$89K ﹤0.01%
16,518

Similar funds

Nuveen's Q3 2024 Portfolio in Review

As of Q3 2024, Nuveen held 3,385 positions worth $356B, up 4.1% from $342B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 3.1%. Nuveen opened 54 new positions and exited 52, leaving the 3,385-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q3 2024 buy was Smurfit Westrock: 13,669,531 shares worth $676M.
  • Nuveen added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, an estimated $269M increase.
  • Nuveen's biggest Q3 2024 reduction was Microsoft, cutting an estimated $542M.
  • Nuveen fully exited iShares MSCI ACWI ETF in Q3 2024, selling an estimated $114M.
  • Nuveen's ten largest holdings make up 30% of its $356B portfolio in Q3 2024.
  • Nuveen opened 54 new positions and closed 52 in Q3 2024.
  • Nuveen's portfolio value rose 4.1% quarter-over-quarter to $356B.

Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.